From: A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults
Average of treatment Group
100 mg IV Ibuprofen
200 mg IV Ibuprofen
400 mg IV Ibuprofen
AUC0-4 (μg.h/mL)
22.33 +/- 12.75 (SD)
32.62 +/- 17.39 (SD)
70.64 +/- 31.93 (SD)